Bullish on Oncology Drug Potential? This Biotech Fund Increases Stake in Enliven Therapeutics Life Science
Eli Lilly Stock Hits Bottleneck After 400% Surge in Five Years, Novo Nordisk Poised for a Comeback with 4% Dividend Yield Life Science
Net Income Soars 66%! CVS Health’s Q1 Results Shatter Slow-Growth Narrative Financial Service, Life Science
Quarterly Sales Reach $8.7 Billion, Eli Lilly’s Mounjaro Becomes New Blockbuster Drug King Life Science